Nutex Health (NASDAQ:NUTX) Stock Price Down 7.7% – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price traded down 7.7% during mid-day trading on Thursday. The stock traded as low as $175.65 and last traded at $174.6090. 56,657 shares were traded during trading, a decline of 66% from the average session volume of 165,841 shares. The stock had previously closed at $189.19.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. B. Riley Financial upped their target price on shares of Nutex Health from $325.00 to $357.00 and gave the company a “buy” rating in a report on Monday. Lake Street Capital raised their price target on Nutex Health from $310.00 to $333.00 and gave the stock a “buy” rating in a report on Monday. Zacks Research cut Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Wall Street Zen downgraded Nutex Health from a “buy” rating to a “hold” rating in a research note on Saturday, October 31st. Finally, Weiss Ratings raised Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $342.00.

Nutex Health Stock Down 9.4%

The company has a current ratio of 4.76, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 7.33 and a beta of 0.66. The firm’s 50 day simple moving average is $203.19 and its 200-day simple moving average is $151.91.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, November 5th. The company reported $5.71 EPS for the quarter, topping the consensus estimate of $5.54 by $0.17. The company had revenue of $217.61 million during the quarter, compared to analysts’ expectations of $214.82 million. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. On average, sell-side analysts anticipate that Nutex Health Inc. will post 27.70 EPS for the current fiscal year.

Insiders Place Their Bets

In other Nutex Health news, Director Scott Saunders sold 203 shares of Nutex Health stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director owned 400 shares of the company’s stock, valued at approximately $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 44.68% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

A number of large investors have recently modified their holdings of the business. Kilter Group LLC acquired a new stake in shares of Nutex Health in the 2nd quarter valued at approximately $27,000. Allworth Financial LP acquired a new position in Nutex Health during the second quarter worth $35,000. GK Wealth Management LLC purchased a new position in Nutex Health in the third quarter worth $73,000. EverSource Wealth Advisors LLC purchased a new position in Nutex Health in the first quarter worth $83,000. Finally, Voya Investment Management LLC acquired a new stake in Nutex Health in the third quarter valued at $206,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.